Overview

5% Topical Ibuprofen (IBU) for Ankle Sprain

Status:
Completed

Trial end date:
2015-02-01

Target enrollment:

Participant gender:

Summary

This study is being conducted to evaluate the effects of IBU 5% Topical Gel versus topical placebo for the relief of pain associated with a first or second degree ankle sprain. Both twice daily and three times daily regimens will be evaluated.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Ibuprofen